Voting Results and Scrutinizer Report of the 23rd Annual General Meeting of theCompany
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jupiter Life Line Hospitals held its 23rd AGM on July 11, 2025 via video conferencing, where all 10 resolutions were passed with overwhelming shareholder support. Voting turnout was strong at about 84% of total shares, with promoters (holding 2.68 crore shares) backing every resolution fully. Shareholders approved the FY25 standalone and consolidated financial statements, declared a final dividend of ₹1 per equity share, and re-appointed Dr. Ankit Thakker as a director. They also appointed KKC & Associates LLP as statutory auditor and Yogesh Sharma & Co. as secretarial auditor, each for a five-year term, and approved a material related party transaction with Jupiter Hospital Projects Private Limited. A special resolution was passed to alter the Memorandum of Association. Dr. Ankit Thakker was appointed as Joint Managing Director for five years effective July 11, 2025, though this resolution saw the relatively highest dissent at 1.7%, driven by about 6.16% of public institutional shareholders voting against.
Routine in nature with all key resolutions passed comfortably, confirming business continuity. The ₹1 per share dividend and five-year appointments of key auditors and Dr. Ankit Thakker as JMD signal stability. The mild institutional pushback on the JMD appointment is worth monitoring but unlikely to materially affect the stock.